Quantcast
Last updated on April 24, 2014 at 16:01 EDT

Latest RAUMEDIC Stories

2013-10-30 08:30:49

LEESBERG, Va., Oct. 30, 2013 /PRNewswire/ -- RAUMEDIC, developer and manufacture of innovative neuromonitoring devices is pleased to announce the 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market NEUROVENT(®)-PTO. NEUROVENT(®)-PTO is the only marketed device that combines three parameters in one catheter to measure intracranial pressure (ICP), intracranial temperature (ICT) and oxygen partial pressure (pti02). (Photo:...